Aurora Spine Corporation
ASAPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $18 | $15 | $15 | $11 |
| % Growth | 21% | -2.4% | 41.1% | – |
| Cost of Goods Sold | $7 | $6 | $7 | $6 |
| Gross Profit | $11 | $8 | $8 | $5 |
| % Margin | 60.5% | 56.5% | 52.5% | 45.8% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $9 | $7 | $6 | $5 |
| SG&A Expenses | $10 | $8 | $7 | $6 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Expenses | $10 | $10 | $9 | $7 |
| Operating Income | $0 | -$1 | -$1 | -$3 |
| % Margin | 1.9% | -10.3% | -9% | -24.2% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$2 | -$3 |
| % Margin | -5.4% | -11.6% | -10.5% | -23.9% |
| EPS | -0.012 | -0.024 | -0.023 | -0.043 |
| % Growth | 48.3% | -1.7% | 45.5% | – |
| EPS Diluted | -0.012 | -0.024 | -0.023 | -0.043 |
| Weighted Avg Shares Out | 78 | 71 | 67 | 59 |
| Weighted Avg Shares Out Dil | 78 | 71 | 67 | 59 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $0 | -$0 | -$1 | -$2 |
| % Margin | 1% | -3.1% | -3.4% | -14.8% |